Blog

  1. April 15, 2024

    Revelation Pharma included in prestigious Pharmacy500 list

    Revelation Pharma included in prestigious Pharmacy500 list

    We're throwing a little party here at Revelation Pharma HQ: We've just been named to the 2024 Pharmacy500 list from RxInsider.

    What's that list, you ask? The official description: "The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year".

    The emphasis is ours because we're incredibly proud of that — of being able to make such a big difference in the compounding pharmacy space in such a short amount of time. The Revelation Pharma vision of innovation and knowledge-sharing covers the country from coast to coast, and it's only getting bigger.

    Our staff is made up of exceptional, dedicated, relentless people, and we're thrilled to see them recognized. (Psst: Did you

    Read More
  2. April 15, 2024

    Revelation Pharma Appoints Brad Leach as Senior Vice President of 503B

    Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.

    With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.

    Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.

    Prior to joining Revelation Pharma,

    Read More
  3. April 12, 2024

    The Most Challenging Places to Live with Allergies: A 2024 Report

    Take a warming climate, a wet spring, and the fact that it's, well, spring, and you have the recipe for a fun-filled allergy season. And by "fun-filled" we mean not fun at all — sniffles, sneezes, watery eyes, and all the joy that comes with an immune system lashing out like a berserk warrior in a role-playing game.

    Some cities, though, are better for allergy sufferers than others — looking at you, Akron, Ohio, (where you'll find the lowest 'allergy burden' among major US cities).

    On the other end of the spectrum, send some thoughts and prayers to Wichita, Kans., which is the worst city to live in if you have seasonal allergies. That's based on "pollen scores for tree, grass, and weed pollen, over-the-counter medication use (allergy), and number of allergy specialists," in a new report (PDF) from the Asthma and Allergy Foundation

    Read More
  4. April 12, 2024

    Patient Case: The Use of Methylene Blue in Canine Methemoglobinemia

    There's an interesting case study in the Journal of Veterinary Internal Medicine about a dog (juvenile, mixed breed) who presented with cyanosis, tachycardia, tachypnea, lethargy, exercise intolerance, and aggression when touched on the head.

    There's a lot going on there. To cut to the chase, a methylene blue IV administration (1 mg/kg) took care of the problem, which turned out to be a pair of gene mutations that led to reductase deficiency and then methemoglobinemia.

    The symptoms returned after 11 days, but a slightly higher dose of the methylene blue fixed the issue and now Fido (not his real name) gets that higher concentration every other day which keeps his methemoglobin concentration at bay.

    Methemoglobinemia can affect different animals differently, and while the solution seems straightforward — methylene blue — it's obviously critical to choose the right concentration and possibly

    Read More
Page